Biopharmaceuticals are shaping the future of modern healthcare and India is well-positioned to emerge as a global leader in this transformative sector. The Government of India is committed to strengthening innovation, manufacturing, clinical research, and regulatory capabilities to make India a leading global biopharmaceutical hub, said Smt. Anupriya Patel, Union Minister of State for Chemicals & Fertilizers.

Speaking at the 2nd Pharma Summit & Awards 2026 organised by ASSOCHAM in New Delhi today the Minister said Biopharma SHAKTI initiative envisages launch of 100 biologics by 2047, contributing directly to the goals of Viksit Bharat and Swasth Bharat. The Minister stated that the Government has created strong funding and policy pathways across the pharmaceutical value chain.

Noting that biologics are expected to account for nearly 40% of prescription drugs by 2031, the Minister emphasized that India must strengthen its capabilities in next-generation biologics while building on its established leadership in affordable generic medicines.

The Minister further highlighted the growing importance of advanced therapies and noted that initiatives such as the PRIP Scheme, National Biopharma Mission are helping create a robust ecosystem for innovation, research, and manufacturing. Industrial and manufacturing-related innovations are being supported through BIRAC initiatives such as the Biotech Ignition Grant, SBIRI, and BIPP. She said these programmes are giving a strong fillip to innovation and called upon the industry to collaborate to place India firmly on the global map of novel biologics, while continuing to strengthen its leadership in small molecules and affordable medicines..

Addressing the gathering Shri Manoj Joshi, Secretary, Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India, stressed on the need to strengthen innovation, accelerate drug discovery, support emerging biopharma capabilities, and build greater supply chain resilience.

Highlighting the transformative potential of the biopharmaceutical sector, he underscored the importance of the Biopharma Shakti Initiative, which aims to position India as a global hub for the development and manufacturing of high-value biologics and biosimilars. He noted that the initiative would strengthen research and innovation, expand clinical research infrastructure, build a skilled workforce, and enhance India’s competitiveness in the global biopharmaceutical value chain

Union Minister of State Smt Anupriya Patel also presented Pharma Excellence Awards to recognize outstanding contributions and achievements across the pharmaceutical sector at the Pharma Summit

***

PC/PM

(रिलीज़ आईडी: 2271807) आगंतुक पटल : 569